Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Clinical trial NCT05582590 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05582590
Sponsor: NexImmune Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Oropharyngeal Cancer Human Papilloma Virus Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Cancer, Metastatic Head and Neck Cancer Metastatic HPV-Related Squamous Cell Carcinoma HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma Relapsed Oropharyngeal SCC Refractory Oropharyngeal Squamous Cell Carcinoma

Start date: 2025-03-31
Primary completion: 2026-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.